Vann Equity Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.36M Sell
5,180
-361
-7% -$92.5K 0.81% 28
2026
Q2
$1.39M Buy
5,541
+50
+0.9% +$10.8K 0.85% 26
2026
Q1
$1.19M Buy
+5,491
New +$1.22M 0.85% 29

Other funds holding ABBV

Vann Equity Management's ABBV Position: Q3 2026 in Review

Vann Equity Management reduced its AbbVie (ABBV) stake by 6.5% in Q3 2026, selling an estimated $92.5K and leaving 5,180 shares worth $1.36M. The position accounts for 0.81% of the portfolio, ranked #28.

Vann Equity Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.39M in Q2 2026. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Vann Equity Management held 5,180 shares of AbbVie worth $1.36M as of Q3 2026.
  • Vann Equity Management sold 361 AbbVie shares in Q3 2026, an estimated $92.5K.
  • AbbVie made up 0.81% of Vann Equity Management's portfolio in Q3 2026, its #28 holding.
  • Vann Equity Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • Vann Equity Management's AbbVie position peaked at $1.39M in Q2 2026.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Vann Equity Management's 13F filing for Q3 2026, filed 8 Oct 2026.